These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Incidence and determinants of migraine prophylactic medication in the Netherlands. Rahimtoola H; Buurma H; Tijssen CC; Leufkens HG; Egberts AC Eur J Clin Pharmacol; 2002 May; 58(2):149-55. PubMed ID: 12012149 [TBL] [Abstract][Full Text] [Related]
4. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J; Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844 [TBL] [Abstract][Full Text] [Related]
5. Resource utilization impact of topiramate for migraine prevention in the managed-care setting. Wertz DA; Quimbo RM; Yaldo AZ; Rupnow MF Curr Med Res Opin; 2009 Feb; 25(2):499-503. PubMed ID: 19192995 [TBL] [Abstract][Full Text] [Related]
6. A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine. Keskinbora K; Aydinli I Clin Neurol Neurosurg; 2008 Dec; 110(10):979-84. PubMed ID: 18620801 [TBL] [Abstract][Full Text] [Related]
7. Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study. Krymchantowski AV; Jevoux CC Headache; 2011 Apr; 51(4):554-8. PubMed ID: 21457240 [TBL] [Abstract][Full Text] [Related]
8. Predictors of a negative response to topiramate therapy in patients with chronic migraine. Rothrock JF; Parada VA; Drinkard R; Zweifler RM; Key KF Headache; 2005; 45(7):932-5. PubMed ID: 15985112 [TBL] [Abstract][Full Text] [Related]
9. Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States. Woolley JM; Bonafede MM; Maiese BA; Lenz RA Headache; 2017 Oct; 57(9):1399-1408. PubMed ID: 28842990 [TBL] [Abstract][Full Text] [Related]
10. Migraine-related healthcare resource use and costs for subjects prescribed fixed-dose combination sumatriptan/naproxen sodium vs. single-entity oral triptans in a managed care population in the USA. Runken MC; Goodwin B; Shah M; Eaddy M; D'Souza A; Bowers B; Bell CF Appl Health Econ Health Policy; 2015 Feb; 13(1):109-20. PubMed ID: 25294555 [TBL] [Abstract][Full Text] [Related]
11. Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis. He A; Song D; Zhang L; Li C J Headache Pain; 2017 Dec; 18(1):26. PubMed ID: 28220376 [TBL] [Abstract][Full Text] [Related]
12. The effect of migraine prophylaxis on migraine-related resource use and productivity. Láinez MJ CNS Drugs; 2009 Sep; 23(9):727-38. PubMed ID: 19689164 [TBL] [Abstract][Full Text] [Related]
13. Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis. Hepp Z; Dodick DW; Varon SF; Chia J; Matthew N; Gillard P; Hansen RN; Devine EB Cephalalgia; 2017 Apr; 37(5):470-485. PubMed ID: 27837173 [TBL] [Abstract][Full Text] [Related]
14. Triptan persistency among newly initiated users in a pharmacy claims database. Katić BJ; Rajagopalan S; Ho TW; Chen YT; Hu XH Cephalalgia; 2011 Mar; 31(4):488-500. PubMed ID: 20937605 [TBL] [Abstract][Full Text] [Related]
15. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine. Mei D; Ferraro D; Zelano G; Capuano A; Vollono C; Gabriele C; Di Trapani G Clin Neuropharmacol; 2006; 29(5):269-75. PubMed ID: 16960472 [TBL] [Abstract][Full Text] [Related]
16. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis. Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129 [TBL] [Abstract][Full Text] [Related]
17. Topiramate for migraine prevention in a naturalistic setting: results from an open label, flexible dose study. Nelles G; Delbrück A; Schulze L; Kademann B; Bornhoevd K; Schäfer S; Schäuble B; Headache; 2009; 49(10):1454-65. PubMed ID: 19804392 [TBL] [Abstract][Full Text] [Related]
18. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ; Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J; Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356 [TBL] [Abstract][Full Text] [Related]